Delivery Order SPE2DB25D3018-SPE2DB25FUYCP
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $26,119.30 for Dupixent 300 mg/2 ml pen (2 ml) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-set-aside, competitively awarded contract. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $46,171.82 for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,144.72 by the Defense Logistics Agency on August 4, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors (2 mL). This competitively awarded, firm fixed-price contract carries no set-aside designation and is scheduled for completion by August 5, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,656.45 on August 29, 2025, for the supply of Dupixent 300 mg/2 ml pens (2 ml units) under a Defense Logistics Agency Medical Supply Chain contract. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 2, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used...
- AmerisourceBergen Drug Corp has been awarded a $92,175.01 delivery order by the Defense Logistics Agency (DLA) for Dupixent 300 mg/2 mL pens, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $50,327.64 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Dupixent 300 mg/2 ml pens. Performance will take place in Conshohocken, Pennsylvania over one day in late June 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies. This delivery order was issued against an...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for Dupixent 300 mg/2 ml pen (2 ml) with a ceiling value of $9,466.60. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 13, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 4, 2025, by the Defense Logistics Agency (DLA) for Dupixent 200 mg/1.14 ml pen auto-injectors. The contract is valued at $1,935.84 with a firm fixed price structure and an ultimate completion date of August 5, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $23,091.45 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Dupixent 300 mg/2 ml pens. Performance will take place in Conshohocken, Pennsylvania over one day in late July 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies. This delivery order was issued against an...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $6,626.93 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply Dupixent 300 mg/2 ml pens. The delivery order, issued under an unspecified agency contract vehicle, calls for the prime contractor Amerisourcebergen to provide 2 ml pens of Dupixent, a prescription medication used to treat certain types of eczema and asthma. Place of performance will be...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYCPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,418.92 by the Defense Logistics Agency for the supply of Dupixent 300 mg/2 mL pens. This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. The delivery order is scheduled for completion by July 31, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic conditions. This delivery order fulfills the Defense Health Agency's medical supply requirements through the DLA Medical Supply Chain, which procures pharmaceuticals and medical supplies to support military and veteran healthcare systems. The award demonstrates AmerisourceBergen's continued role as a critical federal medical vendor and reflects the ongoing need for specialty biologics within the military healthcare system. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 7/30/25 |